A new analysis shows that a combination of two anti-platelets drugs can benefit patients after the most common type of cardiac surgery—while also increasing the risk of potentially dangerous bleeding. This double-edged ...
Aug 9, 2022
0
13
Women who reported recent, regular use of low-dose aspirin (100 milligrams or less) had a 23% lower risk of developing ovarian cancer when compared with women who did not regularly take aspirin, according to new research ...
Oct 4, 2018
0
0
(HealthDay)—Aspirin use may improve survival for bladder and breast cancer, according to a study published online Jan. 15 in JAMA Network Open.
Jan 27, 2021
0
7
New research to be presented at this year's Annual Meeting of the European Association for the Study of Diabetes (EASD) in Hamburg, Germany (2–6 October) shows that use of low dose (100mg daily) aspirin among older adults ...
Aug 31, 2023
0
1
A City of Hope-led study found that the use of low-dose aspirin (81mg) reduces the risk of breast cancer in women who are part of the California's Teacher's Study. This study—which is the first to suggest that the reduction ...
May 1, 2017
0
9
(HealthDay)—Ticagrelor alone results in less bleeding than ticagrelor plus aspirin among high-risk patients who have undergone percutaneous coronary intervention (PCI) and received dual antiplatelet therapy for three months, ...
Sep 27, 2019
0
2
Patients who stopped taking aspirin three months after receiving a stent to open the heart's arteries but continued taking a P2Y12 inhibitor—clopidogrel, prasugrel or ticagrelor—did not experience higher rates of death ...
Mar 18, 2019
0
1
(HealthDay)—There's evidence that daily low-dose aspirin may decrease the risk of pancreatic cancer, according to a new study.
Dec 20, 2016
0
12
Aspirin has been widely used for more than 50 years as a common, inexpensive blood thinner for patients with heart disease and stroke, but doctors have little understanding of how it works and why some people benefit and ...
Jul 3, 2013
0
0
In the largest and longest head-to-head comparison of two anti-clotting medications, warfarin and aspirin were similar in preventing deaths and strokes in heart failure patients with normal heart rhythm, according to late-breaking ...
Feb 3, 2012
0
0
